Various genetic predisposition conditions, such as the JAK2 haplotype, or many other factors may influence the probability of developing an MPN phenotype following acquisition of a somatic JAK2 mutation [12, 30]. This evidence concerns the gene JAK2 and myeloproliferative disorder.